Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BerGenBio ApS
APS
In liquidation
CVR 44311747
Njalsgade 21F, 2.
Business and other management consultancy activities · NACE 7020
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 6,5M
EBITDA margin
3.0%
Equity ratio
30.9%
Financial strength
Net profit 2024
DKK 154K
1 employees
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK 6,5M
—
EBITDA
DKK 192K
—
Net profit
DKK 154K
—
Total assets
DKK 606K
—
Equity
DKK 187K
—
Employees
1
—
Company information
Legal name
BerGenBio ApS
CVR number
44311747
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
19. september 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Virksomhedens formål er at levere management- og rådgivningsydelser samt dermed forbundne aktiviteter.
Contact
Address
Njalsgade 21F, 2.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in København
All Denmark companies
Revenue
DKK millions
0M
2M
3M
5M
7M
6M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
6.482
Staff expenses
-6.290
EBITDA
192
Depreciation & amort.
-0
EBIT
192
Net financials
10
Profit before tax
202
Tax
48
Net profit
154
Balance sheet
DKK thousands
Item
2024
Total assets
606
Equity
187
Long-term debt
0
Short-term debt
418
Total debt
418
Financial ratios
5-year trend
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
2024
2024
Equity ratio
30.9%
This company
38.2%
Market median
+19% vs market
2024
2024
Return on equity
82.1%
This company
18.4%
Market median
+346% vs market
2024
2024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
2024
2024
Asset turnover
10.70×
This company
1.12×
Market median
+855% vs market
2024
2024
Debt / equity
2.23×
This company
0.62×
Market median
-260% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-09-19 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
KM
Kevin Mathas Kristensen
Unofficial title
Unofficial title
2026
BA
BerGenBio ASA
Founder
Founder
2023
Former (2)
MO
Martin Olin
Chief Executive Officer
Chief Executive Officer
2023 – 2024
RS
Rune Skeie
Management
Management
2023 – 2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
BerGenBio ASA
Individual
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BerGenBio ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Kevin Mathas Kristensen
Unofficial title
0 companies
BerGenBio ASA
Founder
0 companies
Martin Olin
Chief Executive Officer
0 companies
Rune Skeie
Management
0 companies